P2.13-12 The deNovo T790M Mutation Recovered by ddPCR is Associated with a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma.

E.Y. Kim; A. Kim; Y.S. Chang

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P2.13-12 The deNovo T790M Mutation Recovered by ddPCR is Associated with a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma.

【24h】

P2.13-12 The deNovo T790M Mutation Recovered by ddPCR is Associated with a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma.

机译：P2.13-12 DDPCR回收的Denovo T790M突变与肺腺癌中的第1和第2代EGFR-TKI的反应不良有关。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第10期|共1页
作者
E.Y. Kim; A. Kim; Y.S. Chang;
展开▼
作者单位

Division of Pulmonology Department of Internal Medicine Yonsei University College of Medicine;

Department of Internal Medicine Yonsei University College of Medicine;

Department of Internal Medicine Yonsei University College of Medicine;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P2.13-12 The deNovo T790M Mutation Recovered by ddPCR is Associated with a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma. [J] . E.Y. Kim, A. Kim, Y.S. Chang Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P2.13-12 DDPCR回收的Denovo T790M突变与肺腺癌中的第1和第2代EGFR-TKI的反应不良有关。
2. Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy [J] . Li Haixia, Wang Chenyu, Wang Ziqi, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：高级肺腺癌患者的疗效和长期存活罕见的EGFR-TKIs治疗，与化疗为一线治疗
3. Detection of plasma T790M mutation after the first generation EGFR-TKI resistance of non-small cell lung cancer in the real world [J] . International journal of applied mechanics . 2020,第3期

机译：在现实世界中非小细胞肺癌第一代EGFR-TKI抗性后检测血浆T790M突变
4. Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma [C] . Yeul Hong Kim, Hye Sook Kim, Jae Sook Sung, Molecular Medicine TRI-CON. . 2014

机译：下一代测序对非小细胞肺癌抗蛋白酶激酶抑制剂进行下一代测序检测的低负荷EGFR突变的预测疗效
5. Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M acquired resistant mutation for first- or second-generation EGFR-TKI [O] . Yusuke Okuma, Yukio Hosomi 2017

机译：奥西替尼用于携带EGFR突变外显子20 T790M的晚期非小细胞肺癌第一代或第二代EGFR-TKI的获得性耐药突变
6. P2.13-12 The deNovo T790M Mutation Recovered by ddPCR is Associated with a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma. [O] . E.Y. Kim, A. Kim, Y.S. Chang 2018

机译：P2.13-12 DDPCR回收的Denovo T790M突变与肺腺癌中的第1和第2代EGFR-TKI的反应不良有关。

P2.13-12 The deNovo T790M Mutation Recovered by ddPCR is Associated with a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma.

著录项

相似文献

相关主题

期刊订阅